Atlas Trials

Marginal Zone Lymphoma(MZL)

29 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Marginal Zone Lymphoma(MZL)

RecordFirmDate
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies (NCT05131022)Nurix Therapeutics, Inc.2022-04-13
Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy (NCT06782854)IRCCS Azienda Ospedaliero-Universitaria di Bologna2022-02-21
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04830137)Nurix Therapeutics, Inc.2021-05-05
Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T (NCT04488354)Calibr, a division of Scripps Research2021-01-21
CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies (NCT04450069)Calibr, a division of Scripps Research2020-08-14
Efficacy and Safety of SHC014748M in Patients With Relapsed or Refractory Follicular (FL) or Marginal Zone (MZL) Lymphoma (NCT04431089)Nanjing Sanhome Pharmaceutical, Co., Ltd.2020-05-09
REal World Data in LYmphoma and Survival in Adults (NCT03869619)Hospices Civils de Lyon2018-11-14
A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML (NCT03547115)MEI Pharma, Inc.2018-05-31
Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0 (NCT03265158)Royal Marsden NHS Foundation Trust2017-07-19

Track Marginal Zone Lymphoma(MZL) automatically

Every clearance here is in the API, with alerts when new ones post.